| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.8B | $1.9B | $2.0B | $1.5B | $1.2B | $0.3B | $0.3B | $0.3B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.4B | $0.4B | $0.3B | $0.9B | $0.4B | $0.1B | $0.2B | $0.1B |
| EPS (Basic) | $1.15 | $1.10 | $1.07 | $2.80 | $1.54 | $0.37 | $0.61 | $0.33 |
| EPS (Diluted) | $1.15 | $1.10 | $1.07 | $2.74 | $1.52 | $0.37 | $0.60 | $0.33 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $63.2B | $62.6B | $69.5B | $79.0B | $83.9B | $80.9B | $78.0B | $68.3B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $0.5B | $0.4B | $0.2B | $0.3B | $0.2B | $0.6B | $0.5B | $0.2B |
| Total Liabilities | $55.7B | $55.4B | $62.5B | $71.8B | $77.2B | $76.0B | $72.9B | $63.4B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $6.8B | $6.4B | $6.3B | $6.5B | $6.1B | $4.5B | $4.7B | $4.6B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.0B | $0.6B | $0.5B | $0.2B | $-1.0B | $1.0B | $-0.0B | $0.6B |
| Investing Cash Flow | $-3.8B | $2.1B | $0.9B | $-3.0B | $-4.3B | $-0.9B | $-0.8B | $-2.5B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $2.9B | $-2.5B | $-1.5B | $2.8B | $4.9B | $0.0B | $0.9B | $2.0B |